REDUCTION IN HIGH BLOOD TUMOR NECROSIS FACTOR-α LEVELS AFTER MANIPULATIVE THERAPY IN 2 CERVICOGENIC HEADACHE PATIENTS

被引:8
作者
Ormos, Gabor [1 ]
Mehrishi, J. N. [2 ,3 ,4 ,5 ]
Bakacs, Tibor [6 ]
机构
[1] HNIRP, Outpatient Clin, Dept Rehabil, H-1023 Budapest, Hungary
[2] Univ Cambridge, Cambridge Blood Initiat, Cambridge, England
[3] Univ Cambridge, Stem Cells Initiat, Cambridge, England
[4] Univ Cambridge, Spermatozoa Initiat, Cambridge, England
[5] Univ Cambridge, Opioid Res Initiat, Cambridge, England
[6] Hungarian Acad Sci, Dept Probabil, Alfred Renyi Inst Math, Budapest, Hungary
关键词
Cervicogenic Headache; Tumor Necrosis Factor-alpha; Musculoskeletal Manipulations; Whiplash Injuries; RHEUMATOID-ARTHRITIS; PATHOPHYSIOLOGY; ANTIBODIES;
D O I
10.1016/j.jmpt.2009.08.006
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: This case report discusses the treatment of 2 patients with cervicogenic headache (CHA) attending the Outpatient Clinic of the Hungarian National Institute for Rheumatology and Physiotherapy (Budapest, Hungary) and reviews the pathophysiology, therapeutic strategy, and problems associated with the treatment of CHA. Clinical Features: Patient 1 was a 27-year-old female who sustained a whiplash injury. A sharp, shooting headache developed, readily induced, and aggravated by just bending the neck backward or by turning her head. Magnetic resonance imaging revealed a disk protrusion at C4-C5 pressing the anterior cerebrospinal space. Patient 2 was a 62-year-old female who sustained a whiplash injury; her cervical movements became restricted, which precipitated headaches. Magnetic resonance imaging revealed a paramedian disk hernia between the C4 and C5 vertebrae that intruded into the right ventral cerebrospinal space. Intervention and Outcome: After 4 weeks of manipulative therapy for patient 1, both active and passive range of motion returned to normal, and the high tumor necrosis factor-alpha (TNF-alpha) level (63 pg/mL) was substantially reduced (28 pg/mL). Patient 2 was started on manipulative therapy twice a week for 4 weeks; after 2 months, the patient became symptom-free, and high TNF-alpha level (72 pg/mL) was reduced greatly (35 pg/mL). Conclusion: Two patients with whiplash injury and disk herniation developed CHA associated with very high TNF-alpha levels. After manipulative therapy, these patients became symptom-free, and their TNF-alpha levels decreased substantially. (J Manipulative Physiol Ther 2009;32:586-591)
引用
收藏
页码:586 / 591
页数:6
相关论文
共 50 条
  • [31] Effects of interferon-α2a treatment on serum levels of tumor necrosis factor-α, tumor necrosis factor-α2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behcet's disease
    Kosar, A
    Haznedaroglu, S
    Karaaslan, Y
    Büyükasik, Y
    Haznedaroglu, IC
    Özath, D
    Sayinalp, N
    Özcebe, O
    Kirazli, S
    Dündar, S
    RHEUMATOLOGY INTERNATIONAL, 1999, 19 (1-2) : 11 - 14
  • [32] Circulating levels of tumor necrosis factor-α correlate positively with severity of peripheral oedema in patients with right heart failure
    Odeh, M
    Sabo, E
    Oliven, A
    EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (02) : 141 - 146
  • [33] Elevation of serum KL-6 levels during treatment with tumor necrosis factor-α inhibitor in patients with psoriasis
    Mabuchi, Tomotaka
    Yamaoka, Hanako
    Kawai, Mayu
    Ota, Tami
    Ozawa, Akira
    JOURNAL OF DERMATOLOGY, 2014, 41 (12) : 1136 - 1137
  • [34] Correlation between polymorphonuclear leukocyte counts and levels of tumor necrosis factor-α in pleural fluid of patients with parapneumonic effusion
    Odeh, M
    Sabo, E
    Srugo, I
    Oliven, A
    LUNG, 2002, 180 (05) : 265 - 271
  • [35] Tumor necrosis factor-α in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood
    Hayashi, M
    Ueda, Y
    Yamaguchi, T
    Sohma, R
    Shibazaki, M
    Ohkura, T
    Inaba, N
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2005, 53 (03) : 113 - 119
  • [36] Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone
    Edwards, Carl K., III
    Green, Julie S.
    Volk, Hans-Dieter
    Schiff, Michael
    Kotzin, Brian L.
    Mitsuya, Hiroaki
    Kawaguchi, Tatsuya
    Sakata, Ken-Mei
    Cheronis, John
    Trollinger, David
    Bankaitis-Davis, Danute
    Dinarello, Charles A.
    Norris, David A.
    Bevilacqua, Michael P.
    Fujita, Mayumi
    Burmester, Gerd-Rudiger
    FRONTIERS IN IMMUNOLOGY, 2012, 3
  • [37] Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor
    Origuchi, Tomoki
    Iwamoto, Naoki
    Kawashiri, Shin-ya
    Fujikawa, Keita
    Aramaki, Toshiyuki
    Tamai, Mami
    Arima, Kazuhiko
    Nakamura, Hideki
    Yamasaki, Satoshi
    Ida, Hiroaki
    Kawakami, Atsushi
    Ueki, Yukitaka
    Matsuoka, Naoki
    Nakashima, Munetoshi
    Mizokami, Akinari
    Kawabe, Yojiro
    Mine, Masanobu
    Fukuda, Takaaki
    Eguchi, Katsumi
    MODERN RHEUMATOLOGY, 2011, 21 (03) : 244 - 250
  • [38] Risk of tuberculosis with anti- tumor necrosis factor- a therapy: substantially higher number of patients at risk in Asia
    Navarra, Sandra V.
    Tang, Boxiong
    Lu, Liangjing
    Lin, Hsiao-Yi
    Mok, Chi Chiu
    Asavatanabodee, Paijit
    Suwannalai, Parawee
    Hussein, Heselynn
    Rahman, Mahboob U.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2014, 17 (03) : 291 - 298
  • [39] Serum neopterin, tumor necrosis factor-α and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus
    Mahmoud, RAK
    El-Gendi, HI
    Ahmed, HH
    CLINICAL BIOCHEMISTRY, 2005, 38 (02) : 134 - 141
  • [40] Release of tumor necrosis factor-α and prostanoids in whole blood cultures after in vivo exposure to low-dose aspirin
    Beckmann, I
    Ben-Efraim, S
    Vervoort, M
    Wallenburg, HCS
    MEDIATORS OF INFLAMMATION, 2001, 10 (02) : 81 - 88